Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other financing activities: 2016-2019

Historic Other financing activities for Organogenesis Holdings (ORGO) over the last 2 years, with Sep 2019 value amounting to $924,000.

  • Organogenesis Holdings' Other financing activities rose 564.75% to $924,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $2.7 million, marking a year-over-year increase of 223.23%. This contributed to the annual value of $5.7 million for FY2020, which is 90.25% up from last year.
  • As of Q3 2019, Organogenesis Holdings' Other financing activities stood at $924,000, which was up 8.83% from $849,000 recorded in Q2 2019.
  • Organogenesis Holdings' Other financing activities' 5-year high stood at $924,000 during Q3 2019, with a 5-year trough of $9,000 in Q1 2018.
  • For the 3-year period, Organogenesis Holdings' Other financing activities averaged around $481,750, with its median value being $500,000 (2017).
  • In the last 5 years, Organogenesis Holdings' Other financing activities crashed by 97.90% in 2018 and then skyrocketed by 8,911.11% in 2019.
  • Over the past 4 years, Organogenesis Holdings' Other financing activities (Quarterly) stood at $294,019 in 2016, then skyrocketed by 94.69% to $572,422 in 2017, then plummeted by 97.90% to $139,000 in 2018, then skyrocketed by 564.75% to $924,000 in 2019.
  • Its Other financing activities was $924,000 in Q3 2019, compared to $849,000 in Q2 2019 and $811,000 in Q1 2019.